Hong Kong - Tiotropium and olodaterol Inhaler

This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.

A local authority has issued a public sector tender for the supply of Tiotropium and Olodaterol Inhalers (2.5 mcg / 2.5 mcg).

Details

Opportunity closing date
13 October 2025
Opportunity publication date
08 September 2025
Opportunity type
Public Sector
Industry
Healthcare services
Enquiries received
0
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

You must be able to supply a minimum quantity of 336,000 units of tiotropium bromide and olodaterol hydrochloride inhalers.

Each product must meet the following requirements:

• each delivered dose must contain 2.5 mcg of tiotropium and 2.5 mcg of olodaterol
• an inhalation device must be provided free of charge
• each product must contain no fewer than 60 doses

Packaging must meet these requirements:

• the immediate container and all levels of packaging of the actual sales pack must include an English translation
• the expiration date must be expressed in English and/or Arabic numerals in a clear and comprehensible format

This is a 3-year contract with a possible extension of up to 24 months. The closing date for this opportunity is 13 October 2025 at 12pm (Hong Kong Time).

Opportunity closing date
13 October 2025
Value of contract
to be confirmed
The buyer is happy to talk to
manufacturers, wholesalers, distributors, agents

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?